Eric P. Lefkofsky Sells 80,003 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 80,003 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $85.78, for a total transaction of $6,862,657.34. Following the completion of the transaction, the chief executive officer now owns 5,049,460 shares of the company's stock, valued at $433,142,678.80. This trade represents a 1.56 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Tempus AI Stock Performance

Shares of NASDAQ TEM traded up $5.69 during trading on Monday, reaching $89.44. 25,048,636 shares of the company traded hands, compared to its average volume of 12,947,475. The firm has a 50 day simple moving average of $47.46 and a 200-day simple moving average of $50.72. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on TEM. Piper Sandler reiterated a "neutral" rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. William Blair downgraded shares of Tempus AI from an "outperform" rating to a "market perform" rating in a research report on Wednesday, February 12th. Wolfe Research initiated coverage on shares of Tempus AI in a research report on Friday, December 13th. They set an "outperform" rating and a $60.00 price objective on the stock. Bank of America increased their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research report on Friday, December 13th. Finally, Guggenheim initiated coverage on shares of Tempus AI in a research report on Monday, December 9th. They set a "buy" rating and a $74.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $58.55.

Institutional Trading of Tempus AI

A number of institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN boosted its holdings in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after buying an additional 278 shares during the last quarter. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI in the third quarter worth approximately $30,000. Geode Capital Management LLC boosted its holdings in shares of Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock worth $7,537,000 after buying an additional 539 shares during the last quarter. Operose Advisors LLC purchased a new position in shares of Tempus AI in the fourth quarter worth approximately $25,000. Finally, Prestige Wealth Management Group LLC boosted its holdings in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after buying an additional 965 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.